Obesity Class Impacts Adverse Maternal and Neonatal Outcomes Independent of Diabetes
- PMID: 35399939
- PMCID: PMC8987983
- DOI: 10.3389/fendo.2022.832678
Obesity Class Impacts Adverse Maternal and Neonatal Outcomes Independent of Diabetes
Abstract
Introduction: Obesity in pregnancy is a known risk factor for adverse maternal and neonatal outcomes. Few studies have compared adverse pregnancy-related outcomes according to obesity severity. Hence, we aimed to examine the impact of obesity class on maternal and perinatal outcomes.
Methods: We retrospectively analysed data from all singleton births from mothers with obesity from 2013-2017 in Northern Sydney Local Health District in Sydney, Australia. Women were categorised into obesity class I (BMI 30-34.9kg/m2), class II (BMI 35-39.9 kg/m2) or class III (BMI 40+ kg/m2). Across BMI classes, we compared maternal outcomes including mode of delivery, gestational diabetes mellitus (GDM), and preeclampsia, and neonatal outcomes including large- and small-for-gestational age (SGA, LGA), neonatal hypoglycaemia, birth defects and timing of birth. Logistic analyses were performed to explore the impact of maternal obesity class on these outcomes, adjusting for maternal age, country of birth, parity, diabetes (both pre-existing and gestational) and hypertension.
Results: There were 2466 births to women with obesity, class (69.1%), class II (21.8%), and class III (9.2%). 42.5% delivered by Caesarean section, 22.3% developed GDM and 11.2% had a hypertensive disorder in pregnancy, and Caesarean section and GDM were more common in women with higher class obesity. LGA occurred in 27.3% and SGA occurred in 4.0% of women across all classes of obesity. LGA rates were 49% more likely in women with class III compared to women with class I obesity (OR=1.49, CI 1.06-2.09, p=0.02). The presence of diabetes in the index pregnancy did not significantly impact risk of neonatal LGA between maternal obesity classes. Other neonatal adverse outcomes such as stillbirth and birth defects were more common in women with higher class obesity. SGA, neonatal hypoglycaemia, gestational age at delivery, APGAR 5-minute score and NICU admissions were similar across obesity classes, after adjustment for covariates.
Conclusions: Obesity class increases the risk of many adverse maternal and neonatal outcomes. Obesity class is independently associated with LGA incidence in the neonate, independent of maternal factors including GDM. Ongoing efforts must be made to reduce obesity incidence in women of reproductive age to circumvent the adverse perinatal outcomes associated with obesity.
Keywords: Caesarean; gestational diabetes; large for gestational age (LGA); obesity; preeclampsia; small for gestation age (SGA); type 1 diabetes; type 2 diabetes.
Copyright © 2022 Neal, Ullah and Glastras.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Clinical consequences of gestational diabetes mellitus and maternal obesity as defined by asian BMI thresholds in Viet Nam: a prospective, hospital-based, cohort study.BMC Pregnancy Childbirth. 2022 Mar 9;22(1):195. doi: 10.1186/s12884-022-04533-1. BMC Pregnancy Childbirth. 2022. PMID: 35264148 Free PMC article.
-
Pregnancy adverse outcomes related to pregravid body mass index and gestational weight gain, according to the presence or not of gestational diabetes mellitus: A retrospective observational study.Diabetes Metab. 2016 Feb;42(1):38-46. doi: 10.1016/j.diabet.2015.06.001. Epub 2015 Jul 2. Diabetes Metab. 2016. PMID: 26141553
-
Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018.Diabetologia. 2024 Mar;67(3):516-527. doi: 10.1007/s00125-023-06066-4. Epub 2024 Jan 5. Diabetologia. 2024. PMID: 38182910 Free PMC article.
-
Interpregnancy weight change and adverse pregnancy outcomes: a systematic review and meta-analysis.BMJ Open. 2018 Jun 4;8(6):e018778. doi: 10.1136/bmjopen-2017-018778. BMJ Open. 2018. PMID: 29866719 Free PMC article.
-
A meta-analysis of metformin and insulin on maternal outcome and neonatal outcome in patients with gestational diabetes mellitus.J Matern Fetal Neonatal Med. 2024 Dec;37(1):2295809. doi: 10.1080/14767058.2023.2295809. Epub 2023 Dec 20. J Matern Fetal Neonatal Med. 2024. PMID: 38124287
Cited by
-
Physical activity, gestational weight gain in obese patients with early gestational diabetes and the perinatal outcome - a randomised-controlled trial.BMC Pregnancy Childbirth. 2024 Feb 2;24(1):104. doi: 10.1186/s12884-024-06296-3. BMC Pregnancy Childbirth. 2024. PMID: 38308265 Free PMC article. Clinical Trial.
-
Mendelian randomization analysis to analyze the genetic causality between different levels of obesity and different allergic diseases.BMC Pulm Med. 2023 Sep 18;23(1):352. doi: 10.1186/s12890-023-02636-9. BMC Pulm Med. 2023. PMID: 37723557 Free PMC article.
-
Combined Effect of Maternal Obesity and Diabetes on Excessive Fetal Growth: Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 2012-2015.AJPM Focus. 2023 Feb 1;2(2):100071. doi: 10.1016/j.focus.2023.100071. eCollection 2023 Jun. AJPM Focus. 2023. PMID: 37790647 Free PMC article.
-
Maternal Obesity as a Risk Factor for Caesarean Delivery in Sub-Saharan Africa: A Systematic Review.Life (Basel). 2022 Jun 17;12(6):906. doi: 10.3390/life12060906. Life (Basel). 2022. PMID: 35743937 Free PMC article. Review.
-
Mexican Clinical Practice Guidelines for Adult Overweight and Obesity Management.Curr Obes Rep. 2024 Dec;13(4):643-666. doi: 10.1007/s13679-024-00585-w. Epub 2024 Oct 2. Curr Obes Rep. 2024. PMID: 39356455 Free PMC article. Review.
References
-
- Australian Institute of Health and Welfare . Australia’s Health 2016. Canberra: AIHW; (2016).
MeSH terms
LinkOut - more resources
Full Text Sources
Medical